The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis.
作者信息
Uzzan B, Pussard E, Leon A, Bekhechi D, Krivitzky A, Modigliani E, Perret G, Vassy R, Berdeaux A, Giudicelli J F
出版信息
Br J Clin Pharmacol. 1991 Mar;31(3):371-2. doi: 10.1111/j.1365-2125.1991.tb05548.x.
Abstract
摘要
相似文献
1
The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis.
Br J Clin Pharmacol. 1991 Mar;31(3):371-2. doi: 10.1111/j.1365-2125.1991.tb05548.x.
2
Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
J Clin Endocrinol Metab. 1994 Feb;78(2):423-7. doi: 10.1210/jcem.78.2.8106631.
3
Amiodarone-induced thyrotoxicosis type 2: a case report and review of the literature.
Am J Med Sci. 2000 Oct;320(4):288-91. doi: 10.1097/00000441-200010000-00012.
4
Effect of high-dose intravenous glucocorticoid therapy on serum thyroid hormone concentrations in type 2 amiodarone-induced thyrotoxicosis: an exploratory study.
J Endocrinol Invest. 2020 Nov;43(11):1637-1643. doi: 10.1007/s40618-020-01252-2. Epub 2020 Apr 16.
5
Amiodarone and thyroid dysfunction.
South Med J. 2010 Sep;103(9):922-30. doi: 10.1097/SMJ.0b013e3181e90500.
6
Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole.
J Endocrinol Invest. 1993 Nov;16(10):823-6. doi: 10.1007/BF03348934.
7
Amiodarone: a common source of iodine-induced thyrotoxicosis.
Horm Res. 1987;26(1-4):158-71. doi: 10.1159/000180696.
8
[Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
Orv Hetil. 2004 Nov 28;145(48):2411-7.
9
Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.
Heart. 1998 Feb;79(2):121-7. doi: 10.1136/hrt.79.2.121.
10
[Selective pituitary resistance to thyroid hormone in a patient treated with amiodarone].
Endocrinol Nutr. 2009 Oct;56(8):418-21. doi: 10.1016/S1575-0922(09)72712-3.
引用本文的文献
1
Drug Dosing in Patients Undergoing Therapeutic Plasma Exchange.
Neurocrit Care. 2021 Feb;34(1):301-311. doi: 10.1007/s12028-020-00989-1.
2
Amiodarone-related thyroid dysfunction.
Intern Emerg Med. 2014 Dec;9(8):829-39. doi: 10.1007/s11739-014-1140-1. Epub 2014 Oct 28.
3
Amiodarone-induced thyroid disorders: a clinical review.
Postgrad Med J. 2000 Mar;76(893):133-40. doi: 10.1136/pmj.76.893.133.
4
Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.
Heart. 1998 Feb;79(2):121-7. doi: 10.1136/hrt.79.2.121.
5
[Therapeutic plasma exchange 1996].
Med Klin (Munich). 1997 Oct 15;92(10):615-20. doi: 10.1007/BF03044789.
6
Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole.
J Endocrinol Invest. 1993 Nov;16(10):823-6. doi: 10.1007/BF03348934.
本文引用的文献
1
Amiodarone in patients on long-term dialysis.
N Engl J Med. 1983 Apr 14;308(15):906. doi: 10.1056/NEJM198304143081518.
2
Amiodarone associated alveolitis and polyarthropathy. Treatment by plasma exchange.
Br Heart J. 1983 Nov;50(5):491-4. doi: 10.1136/hrt.50.5.491.
3
Amiodarone pharmacokinetics.
Am Heart J. 1983 Oct;106(4 Pt 2):840-7. doi: 10.1016/0002-8703(83)90006-6.
4
Tissue extraction of amiodarone and N-desethylamiodarone in man after a single oral dose.
Br J Clin Pharmacol. 1984 Nov;18(5):759-63. doi: 10.1111/j.1365-2125.1984.tb02539.x.
5
Iodine-induced thyrotoxicosis: analysis of eighty-five consecutive cases.
Eur J Clin Invest. 1984 Dec;14(6):449-55. doi: 10.1111/j.1365-2362.1984.tb01212.x.
6
Peripheral neuropathy induced by amiodarone chlorhydrate. A clinicopathological study.
J Neurol Sci. 1984 Feb;63(2):251-66. doi: 10.1016/0022-510x(84)90200-4.
7
Amiodarone.
N Engl J Med. 1987 Feb 19;316(8):455-66. doi: 10.1056/NEJM198702193160807.
Zotero 插件